Impact of doxycycline on Clostridioides difficile infection in patients hospitalized with community-acquired pneumonia

The burden of CDI in the United States: a multifactorial challenge

(2023) Paul Feuerstadt et al.   BMC INFECTIOUS DISEASES

Mortality, Health Care Use, and Costs of Clostridioides difficile Infections in Older Adults

(2022) Paul Feuerstadt et al.   Journal of the American Medical Directors Association

Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America

(2019) Joshua P. Metlay et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

(2018) L Clifford McDonald et al.   CLINICAL INFECTIOUS DISEASES

Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study

(2016) B. Gergely Szabo et al.   CLINICAL MICROBIOLOGY AND INFECTION

Does Doxycycline Protect Against Development of Clostridium difficile Infection?

(2012) S. B. Doernberg et al.   CLINICAL INFECTIOUS DISEASES

Tigecycline Exhibits Inhibitory Activity againstClostridium difficilein the Colon of Mice and Does Not Promote Growth or Toxin Production

(2010) Robin L. P. Jump et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Case-Control Study of Antibiotic Use and Subsequent Clostridium difficile–Associated Diarrhea in Hospitalized Patients

(2007) Roger Baxter et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY